None listed
Conditions
Brief summary
Introduction: Anxiety has a negative influence on the pregnant woman and the fetus, and can cause misleading readings of tests such as fetal cardiotocography and the active period of labor, and influence aspects related to childbirth and pain management. Aromatherapy is a complementary and alternative therapy that generates well-being and allows the mind and body to be treated in a natural way. Objective: to evaluate the role of aromatherapy in reducing anxiety levels, its maternal-fetal benefits, and its influence on the labor process and pain management. Methods: triple-blind randomized clinical trial. The minimum sample size will be 182 full-term and first-time pregnant women, divided into two groups, an intervention group with lavender essence aromatherapy (n=91) and a control group with simulated aromatherapy with distilled water (n=91). Anxiety levels will be measured using Spielberger State-Trait Anxiety Inventory (STAI), physiological parameters of the mother and fetus, and parameters related to the first stage of labor and the degree of pain (VAS scale). Expected results: pregnant women undergoing aromatherapy are expected to have lower levels of anxiety compared to the control group during fetal cardiotocography. Physiological parameters of the mother and fetus and the delivery process and pain management will also improve in the intervention group. Relevance for Health Welfare: There are processes that generate anxiety in pregnant women during the third trimester of pregnancy, such as fetal cardiotocography and the first stage of labor. Midwives can apply non-invasive, non-pharmacological complementary techniques, such as aromatherapy, to promote physio-psychological comfort in women during pregnancy, childbirth and postpartum. Keywords: anxiety; aromatherapy; wellness; pregnancy.
Interventions
Randomized clinical trial with 182 full-term pregnant women divided into two groups during their cardio-fetal follow-up in the hospital: aromatherapy intervention group (n = 91) and control group (n = 91). The intervention group will receive aromatherapy with dispensers containing 100% pure lavender oil essence (4 drops in 300 ml of distilled water). The second midwife, blinded to the intervention, will perform a 20-minute fetal cardiac monitoring and will attend to the pregnant women during the dilation period prior to delivery. Aromatherapy will be used on two occasions: (1) during cardio-fetal follow-up and (2) coinciding with the start of the labor dilatation period. The 20-minute fetal cardiac monitoring will begin at the same time as aromatherapy. The midwife who will apply environmental aromatherapy to pregnant women at term will be responsible for monitoring adherence to the intervention. The duration of the aromatherapy session will be 20 minutes.
Sponsors
Study design
Eligibility
Inclusion criteria
(1) pregnant women of legal age (2) nulliparous (3) term pregnancy (4) without comorbidities (gestational diabetes, eclampsia, preeclampsia, COPD) (5) low-risk singleton pregnancy (6) cephalic presentation (7) vaginal delivery.
Exclusion criteria
(1) obstetric or medical complications of pregnancy that prevented vaginal delivery (2) maternal smell problems (3) multiple gestations (4) women with mental health problems (5) who do not want to voluntarily participate in the study .